ATE26112T1 - Isochinolin-sulfonamidderivate und verfahren fuer ihre herstellung. - Google Patents

Isochinolin-sulfonamidderivate und verfahren fuer ihre herstellung.

Info

Publication number
ATE26112T1
ATE26112T1 AT83111095T AT83111095T ATE26112T1 AT E26112 T1 ATE26112 T1 AT E26112T1 AT 83111095 T AT83111095 T AT 83111095T AT 83111095 T AT83111095 T AT 83111095T AT E26112 T1 ATE26112 T1 AT E26112T1
Authority
AT
Austria
Prior art keywords
group
alkyl group
processes
production
hydrogen atom
Prior art date
Application number
AT83111095T
Other languages
English (en)
Inventor
Hiroyoshi Hidaka
Takanori Sone
Original Assignee
Asahi Chemical Ind
Hiroyoshi Hidaka
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Chemical Ind, Hiroyoshi Hidaka filed Critical Asahi Chemical Ind
Application granted granted Critical
Publication of ATE26112T1 publication Critical patent/ATE26112T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
AT83111095T 1982-11-18 1983-11-07 Isochinolin-sulfonamidderivate und verfahren fuer ihre herstellung. ATE26112T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP57201085A JPS5993054A (ja) 1982-11-18 1982-11-18 イソキノリンスルホン酸アミド誘導体
EP83111095A EP0109023B1 (de) 1982-11-18 1983-11-07 Isochinolin-sulfonamidderivate und Verfahren für ihre Herstellung

Publications (1)

Publication Number Publication Date
ATE26112T1 true ATE26112T1 (de) 1987-04-15

Family

ID=16435138

Family Applications (1)

Application Number Title Priority Date Filing Date
AT83111095T ATE26112T1 (de) 1982-11-18 1983-11-07 Isochinolin-sulfonamidderivate und verfahren fuer ihre herstellung.

Country Status (5)

Country Link
US (2) US4634770A (de)
EP (1) EP0109023B1 (de)
JP (1) JPS5993054A (de)
AT (1) ATE26112T1 (de)
DE (1) DE3370478D1 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61227581A (ja) * 1985-04-02 1986-10-09 Asahi Chem Ind Co Ltd 血管拡張剤
US4678783B1 (en) * 1983-11-04 1995-04-04 Asahi Chemical Ind Substituted isoquinolinesulfonyl compounds
DE3438694A1 (de) * 1984-10-23 1986-04-24 Basf Ag, 6700 Ludwigshafen Neue amidoalkylmelamine und aminoalkylmelamine und verfahren zu ihrer herstellung
DE3583287D1 (de) * 1984-12-27 1991-07-25 Asahi Chemical Ind Substituierte isochinolinsulfonyl-verbindungen.
JPH0667926B2 (ja) * 1985-11-12 1994-08-31 旭化成工業株式会社 環状のイソキノリンスルホンアミド誘導体
US4857301A (en) * 1987-09-25 1989-08-15 Schering Corporation Sulfonamide compounds, compositions and method of use
JPH0215067A (ja) * 1988-07-04 1990-01-18 Hokuriku Seiyaku Co Ltd イソキノリンスルホンアミド誘導体
CA2005741C (en) * 1988-12-26 1998-06-02 Hiroyoshi Hidaka Quinoline sulfonoamino compounds having vessel smooth muscle relaxation activity
US5245034A (en) * 1988-12-26 1993-09-14 Kiroyoshi Hidaka Compound having vessel smooth muscle relaxation activity
DE3942114C2 (de) * 1988-12-26 1997-09-04 Hiroyoshi Hidaka Verbindungen mit einer Wirkung für eine gleichmäßige Gefäßmuskelentspannung und pharmazeutische Zusammensetzung, die diese enthält
US5340811A (en) * 1990-03-08 1994-08-23 Asahi Kasei Kogyo Kabushiki Kaisha Isoquinoline-or quinoline-sulfonamide derivative and a pharmaceutical composition comprising the same
US5326870A (en) * 1991-02-13 1994-07-05 Asahi Kasei Kogyo Kabushiki Kaisha Substituted sulfonamide derivative and a pharmaceutical composition comprising the same
JP2893029B2 (ja) * 1992-08-10 1999-05-17 旭化成工業株式会社 心臓保護剤
ES2205166T3 (es) * 1996-02-02 2004-05-01 D. Western Therapeutics Institute Derivados de isoquinolina y medicamento.
NZ513800A (en) 1996-08-12 2001-09-28 Welfide Corp Treatment of diseases using Rho kinase inhibitors
DE19934272A1 (de) * 1999-07-21 2001-01-25 Bayer Ag Neue antivirale Mittel
EP1479386A1 (de) * 2003-04-30 2004-11-24 Switch Biotech Aktiengesellschaft Verwendung von Isochinolin-Derivaten zur Behandlung und Prophylaxe von Pigmentierungsstörungen
EP1878732B1 (de) * 2005-04-25 2009-02-25 D. Western Therapeutics Institute Hochselektiver rho-kinase-inhibitor
ATE513929T1 (de) * 2006-01-27 2011-07-15 Translational Genomics Res Inst Gene mit einfluss auf die menschliche gedächtnisleistung
EP2061314A4 (de) * 2006-08-10 2010-08-04 Translational Genomics Res Inst Verbindungen zur verbesserung von lernfähigkeit und gedächtnis
CA2664335C (en) 2006-09-20 2014-12-02 Boehringer Ingelheim International Gmbh Rho kinase inhibitors
WO2008049000A2 (en) * 2006-10-18 2008-04-24 United Therapeutics Corporation Combination therapy for pulmonary arterial hypertension
US8455513B2 (en) 2007-01-10 2013-06-04 Aerie Pharmaceuticals, Inc. 6-aminoisoquinoline compounds
US8455514B2 (en) * 2008-01-17 2013-06-04 Aerie Pharmaceuticals, Inc. 6-and 7-amino isoquinoline compounds and methods for making and using the same
US8450344B2 (en) 2008-07-25 2013-05-28 Aerie Pharmaceuticals, Inc. Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
EP2424842B1 (de) * 2009-05-01 2015-10-28 Aerie Pharmaceuticals, Inc. Hemmer mit doppelmechanismus zur behandlung von erkrankungen
EP2444395B1 (de) 2009-06-19 2016-01-06 D. Western Therapeutics Institute, Inc. Substituiertes isochinolinderivat
US8258341B2 (en) * 2009-07-10 2012-09-04 E.I. Du Pont De Nemours And Company Polyfluorosulfonamido amine and intermediate
CA2905089C (en) 2013-03-15 2023-06-13 Aerie Pharmaceuticals, Inc. Isoquinoline compounds for the treatment of ocular diseases
US9643927B1 (en) 2015-11-17 2017-05-09 Aerie Pharmaceuticals, Inc. Process for the preparation of kinase inhibitors and intermediates thereof
AU2015414743B2 (en) 2015-11-17 2019-07-18 Aerie Pharmaceuticals, Inc. Process for the preparation of kinase inhibitors and intermediates thereof
KR102568082B1 (ko) 2016-08-31 2023-08-17 에어리 파마슈티컬즈, 인코포레이티드 안과용 조성물
EP3609871A4 (de) 2017-03-31 2021-01-06 Aerie Pharmaceuticals, Inc. Aryl-cyclopropyl-amino-isochinolinyl-amidverbindungen
CA3112391A1 (en) 2018-09-14 2020-03-19 Aerie Pharmaceuticals, Inc. Aryl cyclopropyl-amino-isoquinolinyl amide compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4097472A (en) * 1974-11-08 1978-06-27 Mitsubishi Chemical Industries Limited N2 -arylsulfonyl-l-argininamides and the pharmaceutically acceptable salts thereof
US4097591A (en) * 1974-11-08 1978-06-27 Mitsubishi Chemical Industries Limited N2 -arylsulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof
IE48623B1 (en) * 1978-08-31 1985-03-20 Mitsubishi Chem Ind Alpha-(n-arylsulfonyl-l-argininamides,processes for their preparation and pharmaceutical compositions containing these substances
US4369320A (en) * 1980-11-03 1983-01-18 E. I. Du Pont De Nemours And Company N-[Heterocyclicaminocarbonyl]-8-quinolinesulfonamides
US4456757A (en) * 1981-03-20 1984-06-26 Asahi Kasei Kogyo Kabushiki Kaisha Isoquinolinesulfonyl derivatives and process for the preparation thereof

Also Published As

Publication number Publication date
EP0109023A1 (de) 1984-05-23
DE3370478D1 (en) 1987-04-30
JPS5993054A (ja) 1984-05-29
US4709032A (en) 1987-11-24
US4634770A (en) 1987-01-06
JPH0428698B2 (de) 1992-05-15
EP0109023B1 (de) 1987-03-25

Similar Documents

Publication Publication Date Title
ATE26112T1 (de) Isochinolin-sulfonamidderivate und verfahren fuer ihre herstellung.
ATE22889T1 (de) 8-chlor-1,5-benzothiazepinderivate, verfahren zur herstellung und pharmazeutische zusammensetzungen.
ATE44954T1 (de) Carbostyrilderivat und verfahren zu seiner herstellung.
NL300396I1 (nl) Nieuwe derivaten met naftalinestructuren, werkwijze voor de bereiding ervan en de farmaceutische preparaten die deze bevatten
CA1238910A (en) CARBOXYALKENOIC ACIDS
DE3873612D1 (de) Dithioacetal-verbindungen, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DK0415456T3 (da) Xanthinforbindelser
FI810389L (fi) Foerfarande foer framstaellning av substituerade imidazolderivat
ES480850A1 (es) Procedimiento para preparar hidantoinas.
ATE26263T1 (de) 1-aryloxy-2,3,4,5-tetrahydro-3-benzazepine, verfahren zur herstellung derselben und ihre verwendung als heilmittel.
PT65019A (de) Phenylalkancarbonsaeure-derivate und verfahren zu ihrer herstellung
ES2000604A6 (es) Un procedimiento para preparar aril-piperidin esteres
FR2593504B1 (fr) Nouveaux derives de dihydrobenzofuranne - et de chromane - carboxamides, leurs procedes de preparation et leur utilisation comme neuroleptiques
DE3751764D1 (de) Verfahren zur Herstellung von N1,N4-Diethylspermin
SE8406302D0 (sv) New aminoguanidine derivatives and a process for the preparation thereof
DK96286A (da) 6-amidino-2-naphthyl-4-amino-benzoat-derivater og farmaceutisk acceptable syreadditionssalte deraf
ATE24503T1 (de) Phenylpiperazin-derivate und verfahren zu deren herstellung.
ATE77818T1 (de) Neue naphthylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung.
DE69324854D1 (de) Pyridazinone-Derivate und Verfahren zur deren Herstellung
ATE41659T1 (de) Benzothiazepinderivate, verfahren zur herstellung und pharmazeutische zusammensetzungen.
ATE46147T1 (de) 4-(nitrophenyl)-tetrahydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
DE3787030D1 (de) 1-carboxy-1-vinyloxyiminoaminothiazol-cephalosporin-derivate und deren herstellung.
ES8704459A1 (es) Procedimiento para la obtencion de acemetacina.
ATE52509T1 (de) Thiazolidinderivate und verfahren zu ihrer herstellung.
ES8106714A1 (es) Procedimiento de preparar derivados 1,2,4-oxadiacinicos

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time